Aarti Sawant‐Basak

493 citations

21 papers · 348 indexed · h-index 10

Biological Psychiatry
Cellular and Molecular Neuroscience top 10%
- Neuropeptides and Animal Physiology 3
Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 4
- Cholinesterase and Neurodegenerative Diseases 3
Behavioral Neuroscience
Pharmacology
- Pharmacogenetics and Drug Metabolism 4
- Cholinesterase and Neurodegenerative Diseases 3
Molecular Biology
- Receptor Mechanisms and Signaling 6
- Pharmacological Receptor Mechanisms and Effects 2
Physiology
- Diet and metabolism studies 3
Pediatrics, Perinatology and Child Health
- Pharmacological Effects and Toxicity Studies 3
Oncology
- Drug Transport and Resistance Mechanisms 2

Co-authors: R. Scott Obach Michelle Vanase‐Frawley Emily Miller Anne W. Schmidt Sarah Grimwood Elaine Tseng Tristan S. Maurer John Freeman
Cited by: Biological Psychiatry Cellular and Molecular Neuroscience Pharmacology
Journals: Journal of Medicinal Chemistry (1 paper)Journal of Pharmacology and Experimental Therapeutics (2 papers)Journal of Cerebral Blood Flow & Metabolism (1 paper)
Partner nations: United States South Korea Poland

In The Last Decade

Aarti Sawant‐Basak

21 papers receiving 340 citations

Peers

Countries citing papers authored by Aarti Sawant‐Basak

Since Specialization

Citations

This map shows the geographic impact of Aarti Sawant‐Basak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aarti Sawant‐Basak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aarti Sawant‐Basak more than expected).

Fields of papers citing papers by Aarti Sawant‐Basak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aarti Sawant‐Basak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aarti Sawant‐Basak. The network helps show where Aarti Sawant‐Basak may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aarti Sawant‐Basak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aarti Sawant‐Basak Line = papers co-authored together Aarti Sawant‐Basak links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Population Pharmacokinetics and Exposure‐Response Analysis of First‐Line Osimertinib Plus Chemotherapy in Patients with EGFR ‐Mutated Advanced NSCLC Clinical Pharmacology & Therapeutics ·Jincheng Yang,Damilola Olabode,Aarti Sawant‐Basak,Richard Baldry,Karthick Vishwanathan,Srinivas Bachina,A. Todd,Dana Ghiorghiu,Yuri Rukazenkov,Diansong Zhou,Azar Shahraz	2025	1
2	Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper Clinical Pharmacology & Therapeutics ·Aarti Sawant‐Basak,Shweta Urva,Jatinder Kaur Mukker,Sebastian Haertter,Dean Mariano,Dolly A. Parasrampuria,Kosalaram Goteti,Ravi Shankar Prasad Singh,Manoj Chiney,Michael Z. Liao,Sandy S. Chang,Rashmi Mehta	2024	2
3	Assessing Trends in Cytokine–CYP Drug Interactions and Relevance to Drug Dosing Drug Metabolism and Disposition ·Aarti Sawant‐Basak,Damilola Olabode,David L. Dai,Karthick Vishwanathan,Alex Phipps	2024	1
4	Investigation of pharmacokinetic drug interaction between clesacostat and DGAT2 inhibitor ervogastat in healthy adult participants Clinical and Translational Science ·Aarti Sawant‐Basak,Arthur Bergman,Jessica Mancuso,Sakambari Tripathy,J Gosset,Laure Mendes da Costa,William P. Esler,Roberto A. Calle	2024	2
5	Investigating CNS distribution of PF‐05212377, a P‐glycoprotein substrate, by translation of 5‐HT₆ receptor occupancy from non‐human primates to humans Biopharmaceutics & Drug Disposition ·Aarti Sawant‐Basak,Laigao Chen,Peter Lockwood,Tracey Boyden,Angela C. Doran,Jessica Mancuso,Kenneth Zasadny,Timothy J. McCarthy,Evan D. Morris,Richard E. Carson,Irina Esterlis,Yiyun Huang,Nabeel Nabulsi,Beata Planeta,Terence Fullerton	2023	2
6	Investigation of CYP3A induction by PF‐05251749 in early clinical development: comparison of linear slope physiologically based pharmacokinetic prediction and biomarker response Clinical and Translational Science ·Jian Lin,François Gaudreault,Nathaniel Johnson,Zhiwu Lin,Parya Nouri,Theunis C. Goosen,Aarti Sawant‐Basak	2022	5
7	Quantitative Translational Analysis of Brain Kynurenic Acid Modulation via Irreversible Kynurenine Aminotransferase II Inhibition Molecular Pharmacology ·Cheng Chang,Kari R. Fonseca,Cheryl Li,W. Elliott Horner,Laura E. Zawadzke,Michelle A. Salafia,Kathryn Welch,Christine A. Strick,Brian Campbell,Steve S. Gernhardt,Haojing Rong,Aarti Sawant‐Basak,Jennifer L. Liras,Amy B. Dounay,Jamison B. Tuttle,Patrick R. Verhoest,Tristan S. Maurer	2018	7
8	Metabolism of a 5HT6 Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug Interaction Drug Metabolism and Disposition ·Aarti Sawant‐Basak,R. Scott Obach,Angela C. Doran,Peter Lockwood,Klaas Schildknegt,Hongying Gao,Jessica Mancuso,Susanna Tse,Thomas A. Comery	2018	6
9	Physiologically Relevant, Humanized Intestinal Systems to Study Metabolism and Transport of Small Molecule Therapeutics Drug Metabolism and Disposition ·Aarti Sawant‐Basak,A. David Rodrigues,Matthew P. Lech,Régis Doyonnas,Marion T. Kasaian,Bhagwat Prasad,Nikolaos Tsamandouras	2018	12
10	Emerging Models of Drug Metabolism, Transporters, and Toxicity Drug Metabolism and Disposition ·Aarti Sawant‐Basak,R. Scott Obach	2018	20
11	Estimation of Circulating Drug Metabolite Exposure in Human Using In Vitro Data and Physiologically Based Pharmacokinetic Modeling: Example of a High Metabolite/Parent Drug Ratio Drug Metabolism and Disposition ·R. Scott Obach,Jian Lin,Emi Kimoto,Sridhar Duvvuri,Timothy Nicholas,Eugene P. Kadar,Larry M. Tremaine,Aarti Sawant‐Basak	2017	9
12	Strategies toward optimization of the metabolism of a series of serotonin-4 partial agonists: investigation of azetidines as piperidine isosteres Xenobiotica ·R. Scott Obach,Erik LaChapelle,Michael A. Brodney,Michelle Vanase‐Frawley,Gregory W. Kauffman,Aarti Sawant‐Basak	2016	9
13	Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects ACS Chemical Neuroscience ·Travis T. Wager,Thomas A. Chappie,David B. Horton,Ramalakshmi Y. Chandrasekaran,Brian Samas,Elizabeth R. Dunn-Sims,Cathleen C. Hsu,Nawshaba Nawreen,Michelle Vanase‐Frawley,Rebecca E. O’Connor,Christopher J. Schmidt,Keith Dlugolenski,Nancy C. Stratman,Mark J. Majchrzak,Bethany L. Kormos,David P. Nguyen,Aarti Sawant‐Basak,Andy Mead	2016	21
14	Determination of receptor occupancy in the presence of mass dose: [¹¹C]GSK189254 PET imaging of histamine H₃ receptor occupancy by PF-03654746 Journal of Cerebral Blood Flow & Metabolism ·Jean‐Dominique Gallezot,Beata Planeta,Nabeel Nabulsi,Donna Palumbo,Xiaoxi Li,Jing Liu,Carolyn Rowinski,Kristin Chidsey,David Labaree,Jim Ropchan,Shu-fei Lin,Aarti Sawant‐Basak,Timothy J. McCarthy,Anne W. Schmidt,Yiyun Huang,Richard E. Carson	2016	35
15	Quantitative projection of human brain penetration of the H₃ antagonist PF-03654746 by integrating rat-derived brain partitioning and PET receptor occupancy Xenobiotica ·Aarti Sawant‐Basak,Laigao Chen,Christopher L. Shaffer,Donna Palumbo,Anne W. Schmidt,Elaine Tseng,Douglas K. Spracklin,Jean‐Dominique Gallezot,David Labaree,Nabeel Nabulsi,Yiyun Huang,Richard E. Carson,Timothy J. McCarthy	2016	5
16	Metabolism of a Serotonin-4 Receptor Partial Agonist 4-{4-[4-Tetrahydrofuran-3-yloxy)-Benzo[d]Isoxazol-3-yloxymethyl]-Piperidin-1-ylmethyl}-Tetrahydropyran-4-ol (TBPT): Identification of an Unusual Pharmacologically Active Cyclized Oxazolidine Metabolite in Human Journal of Pharmaceutical Sciences ·Aarti Sawant‐Basak,Karen J. Coffman,Gregory S. Walker,Tim F. Ryder,Elaine Tseng,Emily Miller,Carlos Lee,Michelle Vanase‐Frawley,John W. Wong,Michael A. Brodney,Tracey L. Rapp,R. Scott Obach	2013	12
17	The 5-Hydroxytryptamine4 Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal θ Oscillations Journal of Pharmacology and Experimental Therapeutics ·David E. Johnson,Elena M. Drummond,Sarah Grimwood,Aarti Sawant‐Basak,Emily Miller,Elaine Tseng,Laura McDowell,Michelle Vanase‐Frawley,Katherine Fisher,David M. Rubitski,K J Stutzman-Engwall,Robin T. Nelson,W. Elliott Horner,Roxanne Gorczyca,Mihály Hajós,Chester J. Siok	2012	47
18	Quantitative PK–PD Model-Based Translational Pharmacology of a Novel Kappa Opioid Receptor Antagonist Between Rats and Humans The AAPS Journal ·Cheng Chang,Wonkyung Byon,Yifeng Lu,Leslie K. Jacobsen,Lori L. Badura,Aarti Sawant‐Basak,Emily Miller,Jing Liu,Sarah Grimwood,Ellen Q. Wang,Tristan S. Maurer	2011	36
19	Pharmacodynamic Model of Sodium–Glucose Transporter 2 (SGLT2) Inhibition: Implications for Quantitative Translational Pharmacology The AAPS Journal ·Tristan S. Maurer,Avijit Ghosh,Nahor Haddish‐Berhane,Aarti Sawant‐Basak,Carine M. Boustany‐Kari,Li She,Michael T. Leininger,Tong Zhu,Meera Tugnait,Xin Yang,Emi Kimoto,Vincent Mascitti,Ralph P. Robinson	2011	28
20	Pharmacological Characterization of 2-Methyl-N-((2′-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a High-Affinity Antagonist Selective for κ-Opioid Receptors Journal of Pharmacology and Experimental Therapeutics ·S. Grimwood,Yang Lü,Anne W. Schmidt,Michelle Vanase‐Frawley,Aarti Sawant‐Basak,Emily Miller,Stafford McLean,John Freeman,Stephen T.C. Wong,Jay P. McLaughlin,Patrick R. Verhoest	2011	52

About Aarti Sawant‐Basak

Aarti Sawant‐Basak is a scholar working on Biological Psychiatry, Pharmacology and Behavioral Neuroscience, having authored 21 papers that have together received 348 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (6 papers), Pharmacogenetics and Drug Metabolism (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Diet and metabolism studies (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Neuropeptides and Animal Physiology (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). The work is most often cited by research in Biological Psychiatry (19 citations), Cellular and Molecular Neuroscience (126 citations) and Pharmacology (47 citations). Aarti Sawant‐Basak has collaborated with scholars based in United States, South Korea and Poland. Frequent co-authors include R. Scott Obach, Michelle Vanase‐Frawley, Emily Miller, Anne W. Schmidt, Sarah Grimwood, Elaine Tseng, Tristan S. Maurer, John Freeman, Michael A. Brodney and Stafford McLean. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Journal of Cerebral Blood Flow & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact